DNMT3B and colon carcinoma: We chose HCT116, a colon carcinoma cell line and its double-knockout derivative (DKO) that has both DNA methyltransferase genes, DNMT1 and DNMT3B knocked out21, for these initial targeting experiments, based on our previous study wherein we demonstrated the presence of the exon 3 pathogenic poly-A in these cell lines19.